You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 14, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Tianci Wang1,2,3, Xin Lai2,3, Shenjie Wang1,2,3
1The Comprehensive Breast Care Center, The Second Affiliated Hospital of Xi'an Jiaotong University, No. 157 Xiwu Road, Xi'an 710004, China.
MRDsteer, an AI-driven agent, enhances circulating tumor DNA (ctDNA) analysis for minimal residual disease (MRD) detection. It improves variant calling stability and sensitivity, especially at ultra-low frequencies, aiding cancer monitoring.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: